Genetic susceptibility in acute pancreatitis

Genotyping of GSTM1, GSTT1, GSTP1, CASP7, CASP8, CASP9, CASP10, LTA, TNFRSF1B, and TP53 Gene Variants

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Objectives Genetic testing could play a critical role in diagnosis and prognosis of acute pancreatitis (AP) and guide effective therapeutic interventions. We hypothesized that genetic polymorphisms in apoptosis and oxidative stress genes could determine incidence or severity in AP. Methods We conducted a hospital-based case-control study in a white Portuguese population (133 AP patients and 232 age- and sex-matched healthy controls) to evaluate the role of 15 gene polymorphisms (2 deletions and 13 single nucleotide polymorphisms [SNPs]) in oxidative stress (GSTM1, GSTT1, GSTP1) and apoptosis genes (CASP7, CASP8, CASP9, CASP10, LTA, TNFRSF1B, TP53) in AP. Criteria for AP were abdominal pain, hyperamylasemia, and contrast-enhanced computed tomography. Results The presence of GSTM1 is associated with increased susceptibility for AP, and the GSTP1 Val105Ile SNP is associated with an increased risk for AP in men. CASP9 Phe136Leu/Phe136Phe SNPs (heterozygotes) increases the risk for mild AP (odds ratio, 3.616; 95% confidence interval, 1.151-11.364; P < 0.05), whereas the homozygotic genotype of CASP9 Ala28Val decreases risk for mild AP (odds ratio, 0.296; 95% confidence interval, 0.091-0.963; P < 0.05). Conclusions Our results suggest that variations in GSTM1, GSTP1, and CASP9 may influence risk for AP.

Original languageEnglish
Pages (from-to)71-76
Number of pages6
JournalPancreas
Volume46
Issue number1
DOIs
Publication statusPublished - Jan 2017

Fingerprint

p53 Genes
Genetic Predisposition to Disease
Pancreatitis
Single Nucleotide Polymorphism
Oxidative Stress
Odds Ratio
Hyperamylasemia
Confidence Intervals
Apoptosis
Genes
Genetic Testing
Genetic Polymorphisms
Heterozygote
Abdominal Pain
Case-Control Studies
Genotype
Tomography
Incidence

Keywords

  • acute pancreatitis
  • apoptosis
  • genetic polymorphisms
  • oxidative stress
  • SNPs

Cite this

@article{f8cc1ad1243247d4ac352aaec5fa970c,
title = "Genetic susceptibility in acute pancreatitis: Genotyping of GSTM1, GSTT1, GSTP1, CASP7, CASP8, CASP9, CASP10, LTA, TNFRSF1B, and TP53 Gene Variants",
abstract = "Objectives Genetic testing could play a critical role in diagnosis and prognosis of acute pancreatitis (AP) and guide effective therapeutic interventions. We hypothesized that genetic polymorphisms in apoptosis and oxidative stress genes could determine incidence or severity in AP. Methods We conducted a hospital-based case-control study in a white Portuguese population (133 AP patients and 232 age- and sex-matched healthy controls) to evaluate the role of 15 gene polymorphisms (2 deletions and 13 single nucleotide polymorphisms [SNPs]) in oxidative stress (GSTM1, GSTT1, GSTP1) and apoptosis genes (CASP7, CASP8, CASP9, CASP10, LTA, TNFRSF1B, TP53) in AP. Criteria for AP were abdominal pain, hyperamylasemia, and contrast-enhanced computed tomography. Results The presence of GSTM1 is associated with increased susceptibility for AP, and the GSTP1 Val105Ile SNP is associated with an increased risk for AP in men. CASP9 Phe136Leu/Phe136Phe SNPs (heterozygotes) increases the risk for mild AP (odds ratio, 3.616; 95{\%} confidence interval, 1.151-11.364; P < 0.05), whereas the homozygotic genotype of CASP9 Ala28Val decreases risk for mild AP (odds ratio, 0.296; 95{\%} confidence interval, 0.091-0.963; P < 0.05). Conclusions Our results suggest that variations in GSTM1, GSTP1, and CASP9 may influence risk for AP.",
keywords = "acute pancreatitis, apoptosis, genetic polymorphisms, oxidative stress, SNPs",
author = "Martins, {Francisco Assis Pereira Oliveira} and Gomes, {Bruno Costa} and AS Rodrigues and J Rueff",
year = "2017",
month = "1",
doi = "10.1097/MPA.0000000000000707",
language = "English",
volume = "46",
pages = "71--76",
journal = "Pancreas",
issn = "0885-3177",
publisher = "Lippincott, Williams & Wilkins",
number = "1",

}

TY - JOUR

T1 - Genetic susceptibility in acute pancreatitis

T2 - Genotyping of GSTM1, GSTT1, GSTP1, CASP7, CASP8, CASP9, CASP10, LTA, TNFRSF1B, and TP53 Gene Variants

AU - Martins, Francisco Assis Pereira Oliveira

AU - Gomes, Bruno Costa

AU - Rodrigues, AS

AU - Rueff, J

PY - 2017/1

Y1 - 2017/1

N2 - Objectives Genetic testing could play a critical role in diagnosis and prognosis of acute pancreatitis (AP) and guide effective therapeutic interventions. We hypothesized that genetic polymorphisms in apoptosis and oxidative stress genes could determine incidence or severity in AP. Methods We conducted a hospital-based case-control study in a white Portuguese population (133 AP patients and 232 age- and sex-matched healthy controls) to evaluate the role of 15 gene polymorphisms (2 deletions and 13 single nucleotide polymorphisms [SNPs]) in oxidative stress (GSTM1, GSTT1, GSTP1) and apoptosis genes (CASP7, CASP8, CASP9, CASP10, LTA, TNFRSF1B, TP53) in AP. Criteria for AP were abdominal pain, hyperamylasemia, and contrast-enhanced computed tomography. Results The presence of GSTM1 is associated with increased susceptibility for AP, and the GSTP1 Val105Ile SNP is associated with an increased risk for AP in men. CASP9 Phe136Leu/Phe136Phe SNPs (heterozygotes) increases the risk for mild AP (odds ratio, 3.616; 95% confidence interval, 1.151-11.364; P < 0.05), whereas the homozygotic genotype of CASP9 Ala28Val decreases risk for mild AP (odds ratio, 0.296; 95% confidence interval, 0.091-0.963; P < 0.05). Conclusions Our results suggest that variations in GSTM1, GSTP1, and CASP9 may influence risk for AP.

AB - Objectives Genetic testing could play a critical role in diagnosis and prognosis of acute pancreatitis (AP) and guide effective therapeutic interventions. We hypothesized that genetic polymorphisms in apoptosis and oxidative stress genes could determine incidence or severity in AP. Methods We conducted a hospital-based case-control study in a white Portuguese population (133 AP patients and 232 age- and sex-matched healthy controls) to evaluate the role of 15 gene polymorphisms (2 deletions and 13 single nucleotide polymorphisms [SNPs]) in oxidative stress (GSTM1, GSTT1, GSTP1) and apoptosis genes (CASP7, CASP8, CASP9, CASP10, LTA, TNFRSF1B, TP53) in AP. Criteria for AP were abdominal pain, hyperamylasemia, and contrast-enhanced computed tomography. Results The presence of GSTM1 is associated with increased susceptibility for AP, and the GSTP1 Val105Ile SNP is associated with an increased risk for AP in men. CASP9 Phe136Leu/Phe136Phe SNPs (heterozygotes) increases the risk for mild AP (odds ratio, 3.616; 95% confidence interval, 1.151-11.364; P < 0.05), whereas the homozygotic genotype of CASP9 Ala28Val decreases risk for mild AP (odds ratio, 0.296; 95% confidence interval, 0.091-0.963; P < 0.05). Conclusions Our results suggest that variations in GSTM1, GSTP1, and CASP9 may influence risk for AP.

KW - acute pancreatitis

KW - apoptosis

KW - genetic polymorphisms

KW - oxidative stress

KW - SNPs

UR - http://www.scopus.com/inward/record.url?scp=85007201100&partnerID=8YFLogxK

U2 - 10.1097/MPA.0000000000000707

DO - 10.1097/MPA.0000000000000707

M3 - Article

VL - 46

SP - 71

EP - 76

JO - Pancreas

JF - Pancreas

SN - 0885-3177

IS - 1

ER -